IDEAYA Biosciences (IDYA) Tops Q3 EPS by 3c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $8.04 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Jefferies Starts Menora Mivtachim Holdings (MMHD:IT) at Buy
• Berenberg Starts Saga Plc. (SGA:LN) at Buy